CCS
CNMD icon

Crosspoint Capital Strategies’s CONMED CNMD Stock Holding History

Crosspoint Capital Strategies’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,384
Closed -$81K – 772
2015
Q2 		$81K Buy
+1,384
New +$74.6K 0.02% 302
2015
Q1 		– Sell
-600
Closed -$27K – 545
2014
Q4 		$27K Buy
+600
New +$25.1K 0.01% 406
2014
Q3 		– Sell
-600
Closed -$24K – 495
2014
Q2 		$24K Buy
600
+375
+167% +$17K 0.01% 319
2014
Q1 		$10K Hold
225
– – ﹤0.01% 468
2013
Q4 		$11K Buy
+225
New +$8.55K ﹤0.01% 414

Other funds holding CNMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Coppersmith Capital Management New York $105M AUM 8.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Crosspoint Capital Strategies's CNMD Position: Q3 2015 in Review

Crosspoint Capital Strategies sold out of CONMED (CNMD) in Q3 2015, closing a stake of 1,384 shares — an estimated $81K sold.

Crosspoint Capital Strategies first reported a position in CNMD in Q4 2013 and held it in 5 quarters. The position peaked at $81K in Q2 2015. 157 funds tracked by Wall St. Rank hold CNMD as of Q3 2015.

  • Crosspoint Capital Strategies reported no remaining CONMED position as of Q3 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 1,384 CONMED shares in Q3 2015, an estimated $81K.
  • Crosspoint Capital Strategies first reported a position in CONMED in Q4 2013 and held it in 5 quarters.
  • Crosspoint Capital Strategies's CONMED position peaked at $81K in Q2 2015.
  • 157 funds tracked by Wall St. Rank held CONMED as of Q3 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2015, filed 25 Nov 2015.